0001213900-23-047567.txt : 20230608
0001213900-23-047567.hdr.sgml : 20230608
20230608184156
ACCESSION NUMBER: 0001213900-23-047567
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230608
DATE AS OF CHANGE: 20230608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: French Anna Louise
CENTRAL INDEX KEY: 0001871871
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39138
FILM NUMBER: 231003341
MAIL ADDRESS:
STREET 1: C/O QIMING U.S. HEALTHCARE
STREET 2: 11100 NE 8TH ST, SUITE 200
CITY: BELLEVUE
STATE: WA
ZIP: 98004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jasper Therapeutics, Inc.
CENTRAL INDEX KEY: 0001788028
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 842984849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 6505491400
MAIL ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp
DATE OF NAME CHANGE: 20190912
4
1
ownership.xml
X0407
4
2023-06-07
0
0001788028
Jasper Therapeutics, Inc.
JSPR
0001871871
French Anna Louise
C/O JASPER THERAPEUTICS, INC.
2200 BRIDGE PKWY, SUITE #102
REDWOOD CITY
CA
94065
1
0
0
0
0
Stock Option (right to buy)
1.60
2023-06-07
4
A
0
47000
0.00
A
2024-06-07
2033-06-07
Voting Common Stock
47000
47000
D
By: /s/ Jeet Mahal, as Attorney-in-Fact
2023-06-08